Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality

Eitemau Tebyg

• Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
  gan: Heart Protection Study Collaborative Group
  Cyhoeddwyd: (2010)
• Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
  gan: Erqou, S, et al.
  Cyhoeddwyd: (2009)
• The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
  gan: Kent, S, et al.
  Cyhoeddwyd: (2016)
• Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
  gan: Thompson, A, et al.
  Cyhoeddwyd: (2010)
• Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
  gan: Parish, S, et al.
  Cyhoeddwyd: (2012)